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tions will continue with both for-profi  t and 
non-profi  t publishers.
Rossner and Mellman (1) have criti-
cized HHMI for not using its infl  uence 
to coerce Elsevier into making their con-
tent public after a short delay without 
compensation. It should be noted that the 
$1,000 we are paying for each Cell Press 
article and $1,500 for other Elsevier pub-
lications is not profi  t to the publisher, but 
a reimbursement for their lost revenue in 
providing accelerated free access and their 
time and effort in uploading HHMI manu-
scripts to PubMed Central. Furthermore, 
HHMI already makes payments at a simi-
lar level to a wide array of non-profi  t and 
for-profi  t publishers for immediate or 
accelerated access to publications, as does 
the Wellcome Trust.
Scholarly publishing is in fl  ux, 
not simply in the biological sciences. 
Virtually all publishers, ranging from 
A reply from HHMI
Tom Cech, Jack Dixon, Avice Meehan, Josie Briggs, and Carl Rhodes
The Howard Hughes Medical Institute 
(HHMI) recently announced a policy on 
Public Access to Publications for its in-
vestigators and Janelia Farm Research 
Campus scientists (http://www.hhmi.org/
about/research/policies.html#papp). This 
policy requires our scientists to publish in 
only those journals that make original re-
search articles and supplemental materials 
freely accessible through a public data-
base within six months of publication.
The policy seeks to balance the goal 
of public access and the equally important 
value of scholarly freedom—the goal of 
our scientists to allow their graduate stu-
dents and postdoctoral fellows to publish 
their work in the journal of their choice. 
To bring more journals into compliance 
with our policy, we have concluded agree-
ments with Elsevier and Cell Press, as well 
as other publishers, including the American 
Society of Hematology. Such conversa-
scientifi  c societies and non-profi  t orga-
nizations to major corporate entities, are 
reconsidering their policies and business 
models. Now that the lid to the open-
access publication box has been opened, 
there’s no closing it again. We applaud 
The Rocke  feller University Press and 
other non-profi  t publishers for taking an 
early lead in providing rapid free access 
to the scientifi  c literature.
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It seems clear from the HHMI response 
that they missed the point of our  Editorial. 
They note that they are providing public 
access to HHMI-funded research with 
their outlay of cash to publishers (both 
commercial and non-commercial). This 
fact was not in dispute.
They do not, however, address the 
effect of their actions on the public access 
movement—that is, the effort to get pub-
lishers (especially commercial publishers, 
who have refused to release the bulk of 
their content to the public) to provide pub-
lic access to their holdings after a short 
delay. If the Rockefeller University Press 
does not need reimbursement to provide 
free access after 6 months, neither should 
other publishers. Elsevier already makes 
vast sums of money publishing publicly 
funded research, and they should feel 
an obligation to give something back to 
the public. Paying publishers to provide 
spotty access to just a few of the papers 
they publish (e.g., those authored by 
HHMI investigators) does not address the 
issue of public access to all of the scien-
tifi  c literature. HHMI had an opportunity 
to exert some pressure on publishers to 
achieve that goal, and they chose not to 
do so. Although they claim they were 
trying to fi  nd a balance between public 
access and “scholarly freedom,” they did 
not succeed. Instead, the public access 
movement has suffered because HHMI 
gave in to the selfi  sh desire of some of 
their investigators to continue publish-
ing in Cell. This serves neither the public, 
nor science. 
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